Cutler Group LP Legend Biotech Corp Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$55.06 - $69.99 $528,576 - $671,904	-9,600 Reduced 88.07%	1,300 $4,000
Q4 2023 Jan 18, 2024	BUY	$57.25 - $69.74 $480,900 - $585,816	8,400 Added 336.0%	10,900 $4,000
Q3 2023 Nov 07, 2023	BUY	$63.16 - $76.5 $138,952 - $168,300	2,200 Added 733.33%	2,500 $12,000
Q2 2023 Jul 18, 2023	SELL	$46.28 - $75.01 $41,652 - $67,509	-900 Reduced 75.0%	300 $0
Q1 2023 May 01, 2023	SELL	$43.42 - $57.37 $842,348 - $1.11 Million	-19,400 Reduced 94.17%	1,200 $1,000
Q4 2022 Feb 07, 2023	BUY	$38.8 - $55.46 $23,280 - $33,276	600 Added 3.0%	20,600 $18,000
Q3 2022 Oct 25, 2022	SELL	$38.15 - $57.1 $175,490 - $262,660	-4,600 Reduced 18.7%	20,000 $67,000
Q2 2022 Aug 04, 2022	BUY	$33.54 - $55.0 $687,570 - $1.13 Million	20,500 Added 500.0%	24,600 $382,000
Q1 2022 Apr 14, 2022	BUY	$31.02 - $48.18 $127,182 - $197,538	4,100 New	4,100 $30,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.25B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.